According to the AP, Neuronetics will hear word from the FDA on January 26, 2007 regarding whether its transcranial magnetic stimulation (TMS) treatment will receive FDA approval for treating depression.
You may recall that the previous date for FDA approval was delayed, as TMS was to scheduled for an FDA decision in October 2006. According to the AP, “FDA postponed the meeting due to general scheduling conflicts, according to Malvern Pennsylvania-based Neuronetics.” If you insist, we’ll buy that story.
Brief review of TMS therapy here.